cbdMD Inc (YCBD) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE MKT. Price $0.49 (-1.76%), Market cap $0.01B, P/E ratio 0.30, 52-week low–high $0.47 ~ $2.27.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce
Financial statements, price targets, institutional (13F) holdings and related news for cbdMD Inc are updated in real time on BlackAll Trade.
cbdMD Inc trades at $0.49 (-1.76%). Real-time quotes and charts are available on BlackAll Trade.
cbdMD Inc has a market cap of about $0.01B. Its P/E ratio is 0.30.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand